Description
Description
Hard gelatine capsules, light brown body and brown lid. The contents of the capsules are a yellow-brown or brown homogeneous mass from oily to a denser texture with a characteristic odor.
Packing
30 pcs.
Pharmacological action
Combined drug, has a hepatoprotective effect, normalizes all types of metabolism (fatty, protein, carbohydrate). Methionine, one of the active components of the drug, is an essential amino acid that is a source of mobile methyl groups. Methionine is necessary for the synthesis of choline. An increase in choline content contributes to an increase in the synthesis of endogenous (internal) phospholipids and to a decrease in the deposition of neutral fat in the liver. Methionine is also necessary for the neutralization of xenobiotics. With atherosclerosis, it reduces the concentration of cholesterol and increases the concentration of blood phospholipids. Essential phospholipids are indispensable factors for the development and functioning of liver cells. The main fraction of essential phospholipids in the preparation is represented by phosphatidylcholine (73%), which is the main component of biological membranes. Once in the body, phosphatidylcholine restores the integrity of the membranes of the affected liver cells and activates the phospholipid-dependent enzymes located in the membrane, thereby normalizing permeability and enhancing the detoxification and excretory potential of liver cells. Methionine and essential phospholipids enhance each other’s action, being a source of endogenous (internal) and exogenous (entering the body) phospholipids, respectively, improve the functional state of liver cells and have a hepatoprotective (protective) effect. Methionine is also involved in the exchange of sulfur-containing amino acids, in the synthesis of epinephrine, creatinine and other biologically active compounds, converts the action of hormones, vitamins (B12, ascorbic acid, folic acid), enzymes, proteins, and participates in the reactions of methylation, deamination, decarboxylation. Eslidine ® restores the function of the liver, increases its detoxification ability, and also normalizes the fat, carbon and protein metabolism in the body.
Indications
The drug is used in gastroenterology, dermatology, neurology, cardiology. Gastroenterology: Fatty liver disease of various etiologies, acute and chronic hepatitis (except for viral) liver cirrhosis, toxic liver damage – alcoholic, narcotic, drug impairment of hepatocyte function (as a complication in other diseases), pre- and postoperative treatment for operations in the hepatobiliary zone. Dermatology: Psoriasis as part of complex therapy. Neurology: Atherosclerosis of the cerebral vessels as part of complex therapy. Endocrinology: Diabetes mellitus as part of complex therapy exhaustion, dystrophy. Cardiology: Atherosclerosis of the coronary arteries as part of complex therapy.
Contraindications
Hypersensitivity (hypersensitivity) to the drug components severe liver failure, hepatic encephalopathy, viral hepatitis, children under 3 years old. With caution, it is possible to use during pregnancy and in children from 3 to 7 years, as well as with renal failure (due to the danger of an increase in hyperazotemia).
Use during pregnancy and lactation
Studies confirming the safety of Eslidine ® for the fetus and safety for the baby during breastfeeding have not been conducted. The use of the drug during pregnancy and lactation is possible only as prescribed by the doctor in cases where the intended benefits to the mother outweigh the possible risk to the fetus and child.
Composition One capsule contains:
Lipoid PPL-400 (phospholipids) (in terms of 100% content of polyunsaturated phospholipids from soya lecithin – PPL fraction) 300 mg,
Methionine (in terms of 100% substance) 100 mg,
Soybean oil up to 550 mg.
Hard gelatin capsules:
Titanium dioxide,
Iron oxide black,
Iron oxide red,
Iron oxide yellow,
Purified water,
Gelatin.
Dosage and administration
The drug is taken orally, with food, swallowed whole, with plenty of water. For liver diseases, atherosclerosis of the coronary arteries and cerebral vessels, diabetes mellitus, dystrophy and exhaustion, take 2 capsules 3 times a day. The recommended course of treatment is 3 months, the minimum is 1 month. With psoriasis – 2 capsules 3 times a day. The recommended course of treatment is 2 weeks. Children over 7 years old with liver diseases, diabetes mellitus, fatty liver disease – 2 capsules 3 times a day, for 1 to 3 months. With psoriasis, children over 7 years old – 2 capsules 3 times a day, for 2 weeks. The use of the drug in children from 3 to 7 years old – 1 capsule 3 times a day, for 1-3 months.
Side effects
Allergic reactions.
Storage conditions
Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Expiration
2 years. Do not use the drug after the expiration date indicated on the package.
Active ingredient
Methylprednisolone aceponate, Fosfolypyd
Terms and conditions
without prescription
dosage form
capsules
Nizhpharm, Russia
